|
Volumn 75, Issue 3, 2008, Pages 257-259
|
Selecting first-line treatment for patients with osteoporosis
|
Author keywords
Adhesion; Compliance; Fractures; Osteoporosis; Strategies for osteoporosis
|
Indexed keywords
PARATHYROID HORMONE[1-34];
RALOXIFENE;
STRONTIUM RANELATE;
ZOLEDRONIC ACID;
BONE ATROPHY;
CARDIOVASCULAR RISK;
CLINICAL DECISION MAKING;
DISEASE SEVERITY;
DRUG USE;
EDITORIAL;
HIGH RISK PATIENT;
HUMAN;
MENOPAUSE;
OSTEOPOROSIS;
PATIENT COMPLIANCE;
POSTMENOPAUSE;
POSTMENOPAUSE OSTEOPOROSIS;
THERAPY EFFECT;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
VERTEBRA FRACTURE;
WOMEN'S HEALTH;
AGE FACTORS;
FEMALE;
FRACTURES, BONE;
HUMANS;
OSTEOPOROSIS;
RISK FACTORS;
|
EID: 42749097438
PISSN: 1297319X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jbspin.2007.11.001 Document Type: Editorial |
Times cited : (4)
|
References (7)
|